Re-Arming the Immunological Radar: The Translational Landscape of Dendritic Cell-Centric Nanotherapeutics and Microenvironment Remodeling for Osteosarcoma
{{output}}
For decades, survival rates in metastatic Osteosarcoma (OS) have starkly plateaued. The persistent failure of immune checkpoint blockade underscores a critical reality: the true therapeutic bottleneck is not merely exhausted T cells, but a profound upstream de... ...